DONALDSON CAPITAL MANAGEMENT, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1487438
EVANSVILLE, IN
Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,337,037
-$55,527 QoQ
Shares Held
18,498
+7.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#789
of 2,266 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DONALDSON CAPITAL MANAGEMENT, LLC holds $353,052,379 across 10 Drug Manufacturers - General names. GILD ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
485,608 | $122,198,397 | |
| 2 | LLY |
ELI LILLY & Co
|
88,678 | $106,363,062 | |
| 3 | MRK |
Merck & Co., Inc.
|
798,673 | $102,629,480 | |
| 4 | JNJ |
Johnson & Johnson
|
37,882 | $9,620,891 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,766 | $4,135,156 | |
| 6 | AMGN |
Amgen Inc
|
8,641 | $3,129,078 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
18,498 | $2,337,037 | |
| 8 | PFE |
Pfizer Inc
|
52,832 | $1,272,194 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,337,037 | 18,498 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,392,564 | 17,167 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,864,297 | 15,189 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,632,144 | 14,704 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,460,601 | 13,174 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,421,802 | 12,689 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,100,588 | 11,915 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,007,756 | 12,020 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $834,640 | 12,165 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $918,408 | 12,538 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,028,664 | 12,698 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $966,351 | 12,895 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $893,780 | 11,597 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $902,962 | 10,883 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $740,456 | 8,625 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $650,212 | 10,540 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $615,998 | 9,966 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $342,610 | 5,763 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $371,908 | 5,122 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $300,285 | 4,299 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $280,811 | 4,078 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $241,069 | 3,730 | Shares | Sole | 2021-05-05 | |
| No filing history on record for this holder in this stock. | ||||||